{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T23:34:33Z","timestamp":1791588873718,"version":"4.3.4"},"reference-count":34,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K23AR077073"],"award-info":[{"award-number":["K23AR077073"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Dermatology"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.clindermatol.2025.09.001","type":"journal-article","created":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T12:53:20Z","timestamp":1757768000000},"page":"681-685","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Comorbidities in prurigo nodularis"],"prefix":"10.1016","volume":"43","author":[{"given":"Jaya","family":"Manjunath","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brenda Umenita","family":"Akinniyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander L.","family":"Kollhoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shawn G.","family":"Kwatra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clindermatol.2025.09.001_bib0001","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/j.jaad.2023.06.045","article-title":"Prevalence and comorbidity burden of prurigo nodularis in United States adults enrolled in the All of Us research program","volume":"89","author":"Joel","year":"2023","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2025.09.001_bib0002","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1001\/jamadermatol.2023.2609","article-title":"Modulation of neuroimmune and epithelial dysregulation in patients with moderate to severe prurigo nodularis treated with nemolizumab","volume":"159","author":"Deng","year":"2023","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.clindermatol.2025.09.001_bib0003","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.1016\/j.jid.2021.02.756","article-title":"A nationwide study of prurigo nodularis: disease burden and healthcare utilization in the United States","volume":"141","author":"Wongvibulsin","year":"2021","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2025.09.001_bib0004","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1056\/NEJMe1916733","article-title":"Breaking the itch-scratch cycle in prurigo nodularis","volume":"382","author":"Kwatra","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clindermatol.2025.09.001_bib0005","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.jaad.2018.04.047","article-title":"Ethnic differences and comorbidities of 909 prurigo nodularis patients","volume":"79","author":"Boozalis","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2025.09.001_bib0006","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1016\/j.jaad.2020.04.183","article-title":"Prurigo nodularis: epidemiology and clinical features","volume":"83","author":"Huang","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2025.09.001_bib0007","doi-asserted-by":"crossref","first-page":"e111","DOI":"10.1016\/j.jaad.2022.05.014","article-title":"Understanding racial disparities in prurigo nodularis","volume":"87","author":"Sutaria","year":"2022","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2025.09.001_bib0008","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1001\/jamadermatol.2023.3251","article-title":"Patient perspectives on living with severe prurigo nodularis","volume":"159","author":"Rodriguez","year":"2023","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.clindermatol.2025.09.001_bib0009","article-title":"INDIVIDUAL ARTICLE: patient journey and the burden of systemic comorbidities and sequalae in prurigo nodularis","volume":"22","author":"Kwatra","year":"2023","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.clindermatol.2025.09.001_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.xjidi.2023.100233","article-title":"Incident comorbidity, resource use, and all-cause mortality associated with prurigo nodularis: a United Kingdom retrospective database analysis","volume":"3","author":"Morgan","year":"2023","journal-title":"JID Innov"},{"key":"10.1016\/j.clindermatol.2025.09.001_bib0011","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1016\/j.jid.2021.02.749","article-title":"Prurigo nodularis is characterized by systemic and cutaneous T helper 22 immune polarization","volume":"141","author":"Belzberg","year":"2021","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2025.09.001_bib0012","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1177\/12034754241227808","article-title":"Abu-Hilal M. Clinical characteristics and treatment outcomes of prurigo nodularis: a retrospective study","volume":"28","author":"Taghaddos","year":"2024","journal-title":"J Cutan Med Surg"},{"key":"10.1016\/j.clindermatol.2025.09.001_bib0013","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.jdermsci.2022.02.004","article-title":"Racial differences in dysregulation of the renin-angiotensin-aldosterone system in patients with prurigo nodularis","volume":"105","author":"Sutaria","year":"2022","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.clindermatol.2025.09.001_bib0014","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2024.105123","article-title":"Increased cardiovascular risks and mortality in prurigo nodularis: a global cohort study","volume":"103","author":"Olbrich","year":"2024","journal-title":"EBioMedicine"},{"key":"10.1016\/j.clindermatol.2025.09.001_bib0015","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jdin.2023.07.015","article-title":"Clinical utility of peripheral blood laboratory testing in the diagnostic workup of prurigo nodularis: a multicenter cohort study","volume":"13","author":"Cornman","year":"2023","journal-title":"JAAD Int"},{"key":"10.1016\/j.clindermatol.2025.09.001_bib0016","first-page":"97","article-title":"Diagnostic workup and evaluation of patients with prurigo nodularis","volume":"6","author":"Kwon","year":"2019","journal-title":"Medicines (Basel)"},{"key":"10.1016\/j.clindermatol.2025.09.001_bib0017","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1111\/ced.14652","article-title":"Association of prurigo nodularis and infectious disease hospitalizations: a national cross-sectional study","volume":"46","author":"Sutaria","year":"2021","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.clindermatol.2025.09.001_bib0018","doi-asserted-by":"crossref","first-page":"743","DOI":"10.3748\/wjg.v23.i5.743","article-title":"Hepatitis C virus-associated pruritus: etiopathogenesis and therapeutic strategies","volume":"23","author":"Alhmada","year":"2017","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.clindermatol.2025.09.001_bib0019","doi-asserted-by":"crossref","first-page":"146","DOI":"10.3390\/genes15020146","article-title":"Dysregulation of the skin-liver axis in prurigo nodularis: an integrated genomic, transcriptomic, and population-based analysis","volume":"15","author":"Marani","year":"2024","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.clindermatol.2025.09.001_bib0020","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.anai.2014.09.010","article-title":"Prurigo nodularis and Hashimoto thyroiditis","volume":"113","author":"Rishi","year":"2014","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.clindermatol.2025.09.001_bib0021","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.jid.2019.07.697","article-title":"Real-world prevalence of prurigo nodularis and burden of associated diseases","volume":"140","author":"Huang","year":"2020","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2025.09.001_bib0022","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.jaad.2019.08.072","article-title":"Racial differences in dermatologic conditions associated with HIV: a cross-sectional study of 4679 patients in an urban tertiary care center","volume":"82","author":"Bender","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2025.09.001_bib0023","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1016\/j.jaad.2019.03.083","article-title":"Association between prurigo nodularis and malignancy in middle-aged adults","volume":"81","author":"Larson","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2025.09.001_bib0024","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1016\/j.jid.2023.12.021","article-title":"Single-cell RNA sequencing reveals dysregulated POSTN+WNT5A+ fibroblast subclusters in prurigo nodularis","volume":"144","author":"Patel","year":"2024","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2025.09.001_bib0025","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1093\/bjd\/ljad500","article-title":"Severity, impact on quality of life and mental health burden of pruritus in prurigo nodularis: a cross-sectional study of a diverse patient cohort","volume":"190","author":"Cornman","year":"2024","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2025.09.001_bib0026","doi-asserted-by":"crossref","first-page":"AB97","DOI":"10.1016\/j.jaad.2022.06.420","article-title":"33202 Prurigo nodularis and mental health disorders among hospitalized patients in the United States","volume":"87","author":"Le","year":"2022","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2025.09.001_bib0027","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1093\/bjd\/ljad121","article-title":"Prurigo nodularis is highly linked with neural sensitization disorders of pain among hospitalized adults in the United States - National Inpatient Sample 2016-2019","volume":"189","author":"Choragudi","year":"2023","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2025.09.001_bib0028","doi-asserted-by":"crossref","DOI":"10.2340\/00015555-3778","article-title":"Impact of itch on sleep disturbance in patients with prurigo nodularis","volume":"101","author":"Gwillim","year":"2021","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.clindermatol.2025.09.001_bib0029","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jdin.2023.07.009","article-title":"Risk of incident sleep disorders in patients with prurigo nodularis: a population-level analysis using The Health Improvement Network","volume":"13","author":"Joel","year":"2023","journal-title":"JAAD Int"},{"key":"10.1016\/j.clindermatol.2025.09.001_bib0030","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1080\/17512433.2021.1852080","article-title":"Pathophysiology, diagnosis, and pharmacological treatment of prurigo nodularis","volume":"14","author":"Williams","year":"2021","journal-title":"Expert Rev Clin Pharmacol"},{"key":"10.1016\/j.clindermatol.2025.09.001_bib0031","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1093\/bjd\/ljae052","article-title":"Prurigo nodularis: new insights into pathogenesis and novel therapeutics","volume":"190","author":"Liao","year":"2024","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2025.09.001_bib0032","doi-asserted-by":"crossref","DOI":"10.1016\/j.xjidi.2024.100281","article-title":"Dupilumab therapy modulates circulating inflammatory mediators in patients with prurigo nodularis","volume":"4","author":"Bao","year":"2024","journal-title":"JID Innov"},{"key":"10.1016\/j.clindermatol.2025.09.001_bib0033","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.jaad.2020.07.025","article-title":"Practical approaches for diagnosis and management of prurigo nodularis: United States expert panel consensus","volume":"84","author":"Elmariah","year":"2021","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2025.09.001_bib0034","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1056\/NEJMoa2301333","article-title":"Phase 3 trial of nemolizumab in patients with prurigo nodularis","volume":"389","author":"Kwatra","year":"2023","journal-title":"N Engl J Med"}],"container-title":["Clinics in Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X25002160?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X25002160?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T08:17:28Z","timestamp":1773130648000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0738081X25002160"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":34,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S0738081X25002160"],"URL":"https:\/\/doi.org\/10.1016\/j.clindermatol.2025.09.001","relation":{},"ISSN":["0738-081X"],"issn-type":[{"value":"0738-081X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comorbidities in prurigo nodularis","name":"articletitle","label":"Article Title"},{"value":"Clinics in Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clindermatol.2025.09.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}